cyproterone acetate has been researched along with levonorgestrel in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (20.69) | 18.7374 |
| 1990's | 11 (37.93) | 18.2507 |
| 2000's | 10 (34.48) | 29.6817 |
| 2010's | 2 (6.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christiansen, C; Marslew, U; Overgaard, K; Riis, BJ | 1 |
| Byrjalsen, I; Christiansen, C; Meinecke, B; Riis, BJ; Thormann, L | 1 |
| Christiansen, C; Haarbo, J; Hassager, C; Jensen, SB; Riis, BJ | 1 |
| Christiansen, C; Marslew, U; Riis, B | 1 |
| Hümpel, M; Li, QG | 1 |
| Jung-Hoffman, C; Kuhl, H | 1 |
| Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N | 1 |
| Huber, J; Spona, J | 1 |
| Kuhl, H; Mehlis, W; Sandow, J; Taubert, HD; Weber, W | 1 |
| Düsterberg, B | 1 |
| Düsterberg, B; Hümpel, M; Speck, U | 1 |
| Kuhnz, W; Löfberg, B | 1 |
| Zaĭdieva, IaZ | 1 |
| Gaspard, UJ; Hendrick, JC; Nervo, P; van den Brûle, FA | 1 |
| Klimenchenko, NI; Smetnik, VP; Zatikian, EP | 1 |
| Cryan, E; Demarest, KT; Granger, K; Gunnet, JW | 1 |
| Andersen, LF; Gram, J; Jespersen, J; Petersen, KR; Sidelmann, J; Skouby, SO | 1 |
| Milsom, I; Odlind, V; Persson, I; Victor, A | 1 |
| Wynn, V | 1 |
| Andersen, LF; Bladbjerg, EM; Jespersen, J; Skouby, SO | 1 |
| de Vries, CS; Farmer, RD; Seaman, HE | 1 |
| Kamischke, A; Nieschlag, E; Zitzmann, M | 1 |
| Anawalt, BD; Bremner, WJ; Matsumoto, AM; McLachlan, RI; Meriggiola, C; Pruysers, E; Robertson, DM; Ugoni, A | 1 |
| Kubán, V; Matejícek, D | 1 |
| Bacquet, A; Balaguer, P; Paris, F; Rabeolina, F; Sultan, C | 1 |
| Tan, JK | 1 |
| Bertina, RM; Dahm, AE; Helmerhorst, FM; Rosendaal, FR; Rosing, J; Sandset, PM; van Vliet, HA | 1 |
| Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P | 1 |
| Hugon-Rodin, J; Plu-Bureau, G; Sabbagh, E | 1 |
2 review(s) available for cyproterone acetate and levonorgestrel
| Article | Year |
|---|---|
Use of progestins in male contraception.
Topics: Asian People; Contraception; Cyproterone Acetate; Desogestrel; Humans; Levonorgestrel; Male; Medroxyprogesterone; Nandrolone; Progestins; Steroids; Testosterone; Time Factors; White People | 2003 |
New developments in hormonal therapy for acne.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 2007 |
7 trial(s) available for cyproterone acetate and levonorgestrel
| Article | Year |
|---|---|
Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
Topics: Bone and Bones; Bone Density; Calcium; Climacteric; Cyproterone; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Middle Aged; Osteoporosis, Postmenopausal; Time Factors; Uterine Hemorrhage | 1992 |
Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy.
Topics: Cyproterone Acetate; Double-Blind Method; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Isocitrate Dehydrogenase; Levonorgestrel; Pregnancy Proteins; Progestins | 1992 |
Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
Topics: Androgen Antagonists; Apolipoproteins; Cyproterone; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Norpregnenes | 1991 |
Progestogens: therapeutic and adverse effects in early post-menopausal women.
Topics: Androgen Antagonists; Climacteric; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Middle Aged; Norgestrel; Severity of Illness Index | 1991 |
Effects of seven low-dose combined contraceptives on vitamin B6 status.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors | 1989 |
Urinary excretion of 6 beta-hydroxycortisol in women during treatment with different oral contraceptive formulations.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Norpregnenes | 1995 |
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.
Topics: Cholesterol, LDL; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Progestins; Risk Factors; Thrombosis; Time Factors; Uterus | 2002 |
20 other study(ies) available for cyproterone acetate and levonorgestrel
| Article | Year |
|---|---|
Serum protein binding characteristics of cyproterone acetate, gestodene, levonorgestrel and norethisterone in rat, rabbit, dog, monkey and man.
Topics: Animals; Binding, Competitive; Blood Proteins; Cyproterone; Cyproterone Acetate; Dogs; Female; Humans; Levonorgestrel; Macaca; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Protein Binding; Rabbits; Radioimmunoassay; Rats | 1990 |
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Efficacy of low-dose oral contraceptives containing levonorgestrel, gestoden and cyproterone acetate.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovulation | 1987 |
Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives.
Topics: Animals; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Luteinizing Hormone; Norethindrone; Norgestrel; Norpregnenes; Rats | 1984 |
Plasma levels of levonorgestrel, gestodene, norethisterone and cyproterone acetate on single-dose subcutaneous administration in oily solution in the rat, beagle and rhesus monkey.
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Dogs; Female; Half-Life; Injections, Subcutaneous; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Norpregnenes; Oils; Radioimmunoassay; Rats; Solutions; Species Specificity; Time Factors | 1984 |
Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys.
Topics: Administration, Oral; Animals; Biological Availability; Cyproterone; Cyproterone Acetate; Dogs; Half-Life; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Norpregnenes; Rats; Species Specificity; Stereoisomerism | 1981 |
[Hormonal therapy in perimenopause].
Topics: Adult; Age Factors; Climacteric; Cyproterone Acetate; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Menopause; Middle Aged; Postmenopause; Syndrome | 1995 |
Absence of antisteroid antibodies in oral contraceptive users presenting with vascular events.
Topics: Adolescent; Adult; Androgen Antagonists; Antibodies; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Immunoenzyme Techniques; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes; Progesterone Congeners; Thrombophlebitis | 1995 |
[Replacement hormonal therapy: effects on ECG parameters in postmenopausal women].
Topics: Androgen Antagonists; Cardiovascular Diseases; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Electrocardiography; Estradiol; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Levonorgestrel; Middle Aged; Postmenopause; Progesterone Congeners | 1998 |
Characterization of the progestin receptors in the human TE85 and murine MC3T3-E1 osteoblast-like cell lines.
Topics: Alkaline Phosphatase; Animals; Cell Line; Centrifugation, Density Gradient; Cyproterone Acetate; Cytosol; Dihydrotestosterone; Estradiol; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mice; Osteoblasts; Progesterone; Protein Binding; Radioligand Assay; Receptors, Progesterone | 1999 |
Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
Topics: Adult; C-Reactive Protein; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Estradiol; Female; Hormone Replacement Therapy; Humans; Levonorgestrel; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Osmolar Concentration; Postmenopause; Progesterone Congeners; Progestins; Reference Values | 2002 |
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis | 2002 |
[Influence of progestins on adverse effects of oral contraceptives].
Topics: Biology; Carbohydrates; Chemical Phenomena; Chemistry; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Disease; Endocrine System; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning Services; Glucose; Hormone Antagonists; Hormones; Levonorgestrel; Lipids; Lynestrenol; Metabolism; Norethindrone; Norethynodrel; Norgestrel; Organic Chemicals; Physiology; Reproductive Control Agents | 1985 |
Differences in the use of combined oral contraceptives amongst women with and without acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Prescriptions; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Polycystic Ovary Syndrome | 2003 |
Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment.
Topics: Contraceptive Agents, Male; Cyproterone Acetate; Desogestrel; Follicle Stimulating Hormone; Humans; Levonorgestrel; Logistic Models; Luteinizing Hormone; Male; Progestins; Sperm Count; Spermatogenesis; Testosterone | 2004 |
High performance liquid chromatography/ion-trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel.
Topics: Chromatography, High Pressure Liquid; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Levonorgestrel; Norpregnenes; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2007 |
Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Animals; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Humans; Levonorgestrel; Norgestrel; Oximes; Protein Binding; Receptors, Androgen; Time Factors; Transfection | 2007 |
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipoproteins; Middle Aged; Protein S; Thrombophilia | 2008 |
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult | 2013 |
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; France; Humans; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Vascular Diseases; Venous Thromboembolism | 2018 |